Related Experiment Video
Updated: Sep 2, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
The Future Evolution of the Mortality Acceleration Due to the COVID-19: The Charlson Comorbidity Index in Stochastic
Maria Carannante1, Valeria D'Amato1, Guido Iaccarino2
1Department of Pharmacy, University of Salerno, Fisciano, Italy.
Insights
Many COVID-19 deaths involve individuals with pre-existing conditions, accelerating mortality. This study forecasts future excess deaths by revising the Charlson Comorbidity Index in a stochastic environment, accounting for individual comorbidities.
Area of Science:
- Epidemiology
- Biostatistics
- Public Health
Background:
- Empirical evidence suggests many COVID-19 fatalities occurred in individuals with pre-existing frailties or comorbidities.
- The concept of mortality acceleration posits that COVID-19 hastens deaths that might have occurred sooner than expected.
Purpose of the Study:
- To forecast future mortality acceleration attributed to COVID-19.
- To quantify the contribution of individual comorbidities to this acceleration.
- To project the future trend of excess deaths linked to COVID-19.
Main Methods:
- Development of a revised Charlson Comorbidity Index within a stochastic framework.
- Application of a post-stratification scheme for unbiased index calculation.
- Analysis of comorbidity impact on mortality acceleration forecasting.
Main Results:
- The revised Charlson Comorbidity Index provides an unbiased measure of comorbidity burden.
- The index varies by age and is centered on the reference population.
- Quantification of each comorbidity's contribution to mortality acceleration is achieved.
Conclusions:
- The study offers a novel method for forecasting COVID-19-related excess mortality.
- Understanding comorbidity's role in mortality acceleration is crucial for public health.
- The revised index can inform future epidemiological and public health strategies.
Abstract:
The empirical evidence from different countries point out many of those who die from coronavirus would have died anyway in the relatively near future due to their existing frailties or co-morbidities. The acceleration of the mortality conceives the underlying insight according to deaths are "accelerated" ahead of schedule due to COVID-19. Starting from this idea, we forecast the future mortality acceleration, based on the deterioration due to the presence of the comorbidities at COVID-19 diagnosis. Accordingly, we explicitly determine the contribution of each comorbidity on the acceleration forecasting, showing the future trend of the excess of deaths due to the COVID-19. To this aim, our proposal consists in developing a revised Charlson Comorbidity Index in a stochastic environment. Based on a post-stratification scheme, we obtain an unbiased comorbidity index that varies by age, centered on the reference population.
More Related Videos
Related Concept Videos
Causality in Epidemiology
Assumptions of Survival Analysis
Parametric Survival Analysis: Weibull and Exponential Methods
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Factors Affecting Illness
For instance, risk factors are connected to illness,...
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Cancer Survival Analysis

